Skip to content
Screener

Quest Diagnostics DGX Total Revenue

Total Revenue at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$200.4M+2.3%
Labcorp Holdings logo
Labcorp HoldingsLH
$3.73B+5.8%
Opko Health logo
Opko HealthOPK
$163.58M+4.3%
NeoGenomics logo
NeoGenomicsNEO
$201.66M+11.2%
Exagen Inc. logo
Exagen Inc.XGN
$17.31M+11.7%
Personalis, Inc. logo
Personalis, Inc.PSNL
$15.47M-24.9%

Segments

By segment

See full
DIS business$2.98B+10.3%
All other operating segments$65M+4.8%

Other financials

Income statement

See full
Gross profit$1.0B+8.9%
Operating income$459.0M+4.8%
Net income$320.0M+13.5%
EPS (diluted)$2.84+15.0%

Balance sheet

See full
Cash & equivalents$626.0M+96.2%
Total debt$6.4B0.0%
Total equity$7.5B+4.0%
Total assets$16.9B+6.1%

Cash flow

See full
Operating cash flow$597.0M+9.7%
CapEx$138.0M+27.8%
Free cash flow$459.0M+5.3%

Valuation

See full
Market cap$27.04B+34.5%
Enterprise value$32.8B+25.3%
P/E25.5×+4.3×
P/S2.3×+0.4×

Profitability

See full
Gross margin33.1%+0.1pp
Operating margin14.1%+0.1pp
Net margin9.2%+0.2pp
FCF margin11.7%0.0pp

Returns & leverage

See full
Return on equity14.4%+0.7pp
Debt / equity0.8×0.0×
Current ratio1.6×+0.5×

Where this comes from

Reported directly by Quest Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Quest Diagnostics’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:16 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001022079-26-000070
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Net revenues$3,043$2,761$5,938$5,413
Operating costs and expenses and other operating income:
Cost of services2,0161,8183,9693,607
Selling, general and administrative5294861,033962
Amortization of intangible assets38397578
Other operating expense (income), net1(20)3(18)
Total operating costs and expenses, net2,5842,3235,0804,629
Operating income459438858784

Cover / Front Matter

FAQ

What is Quest Diagnostics's total revenue?
Quest Diagnostics (DGX) reported total revenue of $3.04B in Q2 2026.
How has Quest Diagnostics's total revenue changed year-over-year?
Quest Diagnostics's total revenue increased by 10.2% year-over-year, from $2.76B to $3.04B.
What is the long-term trend for Quest Diagnostics's total revenue?
Over 4 years (2021 to 2025), Quest Diagnostics's total revenue has grown at a 0.6% compound annual growth rate (CAGR), from $10.79B to $11.04B.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Quest Diagnostics's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude